Previous Article | Next Article 
Journal of Clinical Microbiology, February 2001, p. 696-704, Vol. 39, No. 2
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.2.696-704.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Typing and Subtyping Influenza Virus Using DNA
Microarrays and Multiplex Reverse Transcriptase PCR
Jiping
Li,1,2
Shu
Chen,2 and
David H.
Evans1,*
Department of Molecular Biology and
Genetics1 and Laboratory Services
Division,2 The University of Guelph, Guelph,
Ontario N1G 2W1, Canada
Received 21 September 2000/Accepted 15 November 2000
 |
ABSTRACT |
A model DNA microarray has been prepared and shown to facilitate
typing and subtyping of human influenza A and B viruses. Reverse
transcriptase PCR was used to prepare cDNAs encoding ~500-bp influenza virus gene fragments, which were then cloned, sequenced, reamplified, and spotted to form a glass-bound microarray. These target
DNAs included multiple fragments of the hemagglutinin, neuraminidase,
and matrix protein genes. Cy3- or Cy5-labeled fluorescent probes were
then hybridized to these target DNAs, and the arrays were scanned to
determine the probe binding site(s). The hybridization pattern agreed
perfectly with the known grid location of each target, and the
signal-to-background ratio varied from 5 to 30. No cross-hybridization
could be detected beyond that expected from the limited degree of
sequence overlap between different probes and targets. At least 100 to
150 bp of homology was required for hybridization under the conditions
used in this study. Combinations of Cy3- and Cy5-labeled DNAs can also
be hybridized to the same chip, permitting further differentiation of
amplified molecules in complex mixtures. In a more realistic test of
the technology, several sets of multiplex PCR primers that collectively
target influenza A and B virus strains were identified and were used to
type and subtype several previously unsequenced influenza virus isolates. The results show that DNA microarray technology provides a
useful supplement to PCR-based diagnostic methods.
 |
INTRODUCTION |
After the first reports describing
DNA microchip arrays appeared (15, 16), microarray
technology revolutionized the study of gene expression patterns in
diverse organisms (reviewed in references 3 and 7). Arrays
composed of oligonucleotides (15) or robotically spotted
DNAs (16) permit genome scale analysis of gene expression
patterns and have more recently been used in such applications as drug
discovery (6), mutation detection (8, 9, 12),
evolutionary studies (11, 21), and genome mapping
(20). The application of DNA microarray technology as a
diagnostic tool also shows great promise, since microarrays theoretically permit a simultaneous screen for any of tens of thousands
of nucleic acid sequences. However, only recently have reports of these
array-based applications started to appear. Oligonucleotide arrays have
been used to search for mutations in cancer-linked genes (reviewed in
reference 10) and human immunodeficiency virus mutations
(13, 25) and in bacterial typing (1), but the
high cost and limited availability of such tools continue to limit
research in this area.
We have been interested in the development of new technologies capable
of better identifying viral pathogens and have been using, as a model
system, human influenza viruses (28, 29). Influenza
viruses cause annually recurrent epidemics of moderate-to-severe respiratory disease, frequently associated with genetic variation termed drift and shift (5, 27). These viruses present an important diagnostic problem, and the rapid detection, typing, and
subtyping of influenza A and B virus strains are of both clinical and
epidemiological value. While antibody-based methods still form the
foundations of routine diagnostic work, many reports over the last
decade have demonstrated the utility and superiority of PCR-based
diagnostic (2, 4, 14, 19, 22, 26) and retrospective
(23) tests. Unfortunately PCR-based methods suffer from a
problem in that simply producing DNA isn't sufficient evidence that
one has amplified the right product. Other methods such as DNA
sequencing (29), blotting (18), and
fluorogenic PCR (19) are required if one desires proof
that a PCR has amplified a bona fide nucleic acid target. While such
confirmatory methods are certainly reliable, they still present
something of a financial, technical, and logistical challenge to busy
laboratories routinely screening for hundreds of different agents. They
also become more difficult to apply when multiplex methods are being
used to simultaneously amplify two or more PCR products from a mixture
of templates.
DNA arrays offer a potential solution to these problems. The arrays can
potentially encode tens of thousands of possible target sequences and
thus provide a simple way of storing and indexing numerous
hybridization probes. In principle one could draw this resource when
needed to confirm the identity of one or more PCR products by
hybridization, with only minimal modification to existing PCR-based
protocols. We have tested this approach and show here that a model DNA
array can be used to type and subtype influenza A and B virus strains.
This shows that DNA arrays can provide multiply redundant confirmatory
evidence that a PCR product encodes the sequence(s) it is expected to encode.
 |
MATERIALS AND METHODS |
Viruses.
Human influenza virus strains (Table
1) were obtained from the American Type
Culture Collection (Manassas, Va.) and propagated where necessary in
10-day-old embryonated chicken eggs (29). Crude viral RNA
was extracted as described previously (29) and stored at
70°C.
Oligonucleotide primer design.
Oligonucleotide primers were
designed using RightPrimer, version 1.2, software and GenBank Blastn
sequence alignments. Selected PCR primers meet the following criteria:
(i) primers hybridize to highly conserved sequence elements, (ii) each
amplicon spans approximately 500 bp, (iii) amplified segments
collectively encompass an entire gene (thus 1.5 kb of virus DNA
sequence required three primer pairs), and (iv) primer melting points
generally fell between 50 and 54°C. Desalted primers were purchased
from Gibco/BRL and used without further purification.
RT-PCR and cDNA cloning.
A commercial kit was used to
prepare viral cDNAs. Reaction mixtures contained 10 pg of RNA, 200 µM
(each) deoxynucleoside triphosphate, 1.5 mM MgCl2, 0.4 µM
(each) primer, and other components as directed by the manufacturer
(Titan one-tube reverse transcriptase PCR [RT-PCR] kit [Roche]).
Reaction mixtures were incubated at 50°C for 30 min, denatured at
94°C for 3 min, and then subjected to 35 thermal cycles (94°C for
30 s, 45°C for 30 s, 68°C for 2 min). Following a final
10-min incubation at 68°C, the samples were chilled and the products
were sized by electrophoresis. PCR-amplified viral cDNAs were
subsequently cloned using a Topo TA cloning kit (Invitrogen).
Recombinant plasmids were purified from lacZ mutant bacteria
and sequenced as described previously (24).
Preparation of target DNAs.
M13 forward (5'
GTAAAACGACGGCCAGTG 3') and reverse (5' CAGGAAACAGCTATGACC
3') primers were used to reamplify cloned viral cDNAs. The
reverse primer incorporated an amine tag linked by a six-carbon spacer
to the 5' end (Gibco/BRL). PCR mixtures (100 µl) contained 2 mM
MgCl2, 200 µM (each) deoxynucleoside triphosphate, 0.4 µM (each) primer, ~1 ng of purified plasmid DNA, 1/10-diluted enzyme buffer, and 1.5 U of Taq polymerase (Perkin-Elmer).
Following 35 thermal cycles (typically 94°C for 30 s, 52°C for
30 s, 72°C for 1 min) the DNA was purified using MicroSpin S-400
columns (Amersham/Pharmacia Biotech), precipitated with ethanol,
resuspended in 30 µl of 3× SSC (10× SSC is 87.6 g of
NaCl/liter and 44.1 of sodium citrate/liter, pH 7.0), and the DNA
concentration was adjusted to ~300 ng/µl for spotting purposes.
Microarray printing and processing.
Amine-tagged target DNAs
were distributed, in duplicate, into 384-well microtiter plates. A
custom-built arrayer (Virtek) was used to spot DNA on
aldehyde-activated silylated microscope slides (CEL Associates).
Printed arrays were air dried for a few minutes at 50 to 60°C and
then stored overnight at 20 to 37°C over desiccant. The arrays were
rehydrated for 4 h in a humid atmosphere, dried briefly at 50°C
on a heating block, washed once in 0.2% sodium dodecyl sulfate (SDS)
and twice in water (1 min each), and treated with sodium borohydride
(1.0 g of NaBH4 [Sigma] dissolved in 300 ml of
phosphate-buffered saline plus 100 ml of ethanol [17])
for 5 min. The DNA was denatured in water (2 min at 95°C) and then
washed again (once in 0.2% SDS and once in water [1 min each]).
Arrays were air dried and stored at room temperature.
Probe preparation and multiplex PCR.
Two methods for
incorporating fluoro-linked Cy3- and/or Cy5-dCTP (Amersham/Pharmacia
Biotech) into fluorescent probes were devised. The simplest method
involved adding 20 µM Cy3- or Cy5-dCTP to a standard 100-µl PCR
mixture containing Taq polymerase; 200 µM (each) dATP,
dGTP, and TTP plus 100 µM dCTP; and a single primer pair (see above).
In subsequent experiments, probes were prepared using multiplex RT-PCR
mixtures also supplemented with 20 µM Cy3- or Cy5-dCTP. In this case
the primers were combined into three different groups, but in such a
way that the combination of primers ensured that one influenza virus
subtype could be amplified no matter which viral RNA or cloned cDNA was
present. Labeled probes were purified using MicroSpin S-300 columns and
heat denatured before hybridization. Fluorescent molecules were handled
under dim lighting to minimize photobleaching.
Hybridization and data analysis.
Microarrays were
prehybridized in 20 µl of DIG Easy Hyb (Roche) containing 5 µg of
denatured salmon sperm DNA at 62°C for 1 h under a 12- by 12-mm
coverslip. The coverslip was washed off the slide in 0.1× SSC, and the
slides were dried at room temperature. A fresh solution of DIG Easy
Hyb, containing ~5 µl of denatured fluorescent probe plus 5 µg of
salmon sperm DNA in a total volume of 20 µl, was then applied to the
array and overlaid with a 12- by 12-mm coverslip. The arrays were
incubated overnight at 58 to 62°C in a humid chamber and then washed
for 5 min at 20°C in 1× SSC-0.1% SDS followed by 0.1× SSC-0.1%
SDS. The arrays were rinsed in 0.1× SSC, dried, and stored in the
dark. Arrays were analyzed using GenePix (Axon Instruments) or
ChipReader (Virtek) confocal scanners, and the fluorescence was
quantitated using ImaGene software (Biodiscovery). Gain settings
produced a linear detector response. A "glass" background
fluorescence reading was measured in the region surrounding each spot
and subtracted, and the intensity was normalized to produce an average
fluorescence reading at all nonhomologous spot positions equal to 50 U. The signal-to-background ratios reported here are the fluorescence intensities measured at homologous spots divided by an average measured
at all other array locations.
Nucleotide sequence accession numbers.
Viral sequences
obtained in this study have been assigned GenBank accession no.
AF305216 to AF305220.
 |
RESULTS |
Viral genetic targets.
Three types of human influenza viruses
are commonly encountered (A, B, and C), of which the A and B types are
of primary clinical interest. Type A strains are further subtyped as
encoding one of three different hemagglutinins (HAs; H1, H2, or H3) and
one of two different neuraminidases (N1 or N2). The HA and
neuraminidase (NA) genes are principal pathogenic determinants that
reside on separate subgenomic segments, and it is genetic reassortment
of these segments which creates the six primary human influenza A virus
subtypes which change over decades. Human type B influenza virus
strains also encode HA and NA genes, but only a single major genetic
variant of each is commonly encountered. Thus the typing and subtyping
of influenza A and B virus strains require an ability to detect at
least four HA and three NA genes plus their drifted allelic variants.
Other viral genes are also useful in differentiating influenza A and B
virus strains and offer the advantage of being more genetically stable.
In this regard we have previously used the influenza matrix protein
(MP) gene as a PCR target. Methods capable of differentiating a total
of four HA, three NA, and two MP gene targets thus provide the capacity
to type and subtype human influenza A and B virus strains with some
degree of redundancy.
Preparation of cloned virus cDNAs.
We initially cloned
multiple separate fragments of genes for three influenza A virus HAs
(A/HA1, A/HA2, and A/HA3), two influenza A virus NAs (A/NA1 and A/NA2),
and an influenza A virus MP (A/MP) as well as an influenza B virus HA
(B/HA), NA (B/NA), and MP (B/MP). The nine genes each spanned 1 to 1.5 kb and have little or no sequence homology. Primers were selected using
a combination of primer design software and Blastn sequence alignments
with the intent of locating each primer pair in maximally conserved
sequence regions spaced about 500 bases apart. Table
2 lists the nine DNA sequences used to
initiate homology searches and to design primers, and Table
3 shows the 52 primers generated by this
approach. Based on available sequence data, the variation in nucleotide sequence within each influenza gene family ranges from 81 to 100% sequence identity (Table 2). These 26 primer pairs were used in RT-PCRs
to amplify genes encoded by five different influenza virus strains
(Table 1). We obtained 24 of 26 possible cDNA products (the A/HA1-2 and
B/MP-2 primer sets did not work), cloned these cDNAs, and verified the
DNA sequences.
Array fabrication.
The 24 sequence-validated cDNA clones were
reamplified using M13 universal primers, in the process adding a 5'
amino tag to the reverse primer to permit covalent attachment to a
modified glass support. A custom-built Stanford-type DNA arrayer was
used to spot DNA, in duplicate, onto activated silylated glass slides at densities of 1,100 or 2,500 spots/cm2 (300- or 200-µm
spacing, respectively). The array pattern is shown in Table
4. In addition to virus cDNAs we added
control spots composed of Escherichia coli DNA and 3× SSC
buffer. Several replicate sets of the eight-by-eight grid were also
printed elsewhere on the slide to facilitate statistical analysis of
hybridization signals.
Hybridization of arrays with cloned cDNAs.
To determine
whether these arrayed cDNA targets retained their expected
hybridization properties, we first tested whether fluorescent probes
derived from the original cloned cDNA templates would hybridize to a
cognate spot(s). Standard PCR mixtures were supplemented with Cy3-dCTP
and used to reamplify each of the cloned cDNAs. These fluorescent
probes were purified and individually hybridized to separate arrays,
and then the hybridization signals were analyzed using Virtek or Axon
chip readers. A selection of the resulting fluorescence images are
shown in Fig. 1 (panels 1 to 6). These
can be decoded by noting, for example, that a 520-bp A/HA3-1 probe
(Table 3) produced strong hybridization signals at duplicate spots
located in row 3, columns 1 and 2 (Fig. 1, panel 2). Overall, duplicate
hybridization signals were clearly detected at all of the positions
known to encode homologous DNA targets and little cross-hybridization
to unrelated spots or background fluorescence was detected with these
supports.

View larger version (98K):
[in this window]
[in a new window]
|
FIG. 1.
Identification of influenza cDNAs using glass-supported
microarrays. DNA targets were spotted in duplicate in an eight-by-eight
grid, and bound probes were detected using confocal fluorescence
microscopy. The hybridization probe or probes used in each experiment
are indicated below each image, and the array pattern is shown in Table
4. The images seen in panels 1 to 6 were obtained using short probes
spanning mostly a single target (see text for a further discussion of
this point), while panel 7 shows an array hybridized to a longer cDNA
fragment spanning three contiguous targets (A/HA3-1, A/HA3-2, and
A/HA3-3). The single array shown in panels 8 and 9 was hybridized to a
mixture of Cy3-labeled
A/HA2-1 probes and Cy5-labeled B/NA-1 probes and scanned
simultaneously for Cy3 (panel 8) and Cy5 (panel 9) dyes at excitation
wavelengths of 543 and 635 nm, respectively. For comparison, panel 10 shows another array hybridized to a mixture of Cy3-labeled A/HA2-1 and
B/NA-1 probes. Panels 11 and 12 illustrate the use of multiplex RT-PCR
and the ability to detect hybridization of heterologous A/Denver/1/57
and B/Hong Kong/5/72 probes to A/Port Chalmers/1/73 and B/Maryland/1/59
targets.
|
|
The digital images generated by fluorescence scanners can be very
misleading if judged just by eye, because the appearance varies greatly
in response to changes in instrument settings, background subtraction,
and postacquisition gain factors. Therefore we also measured the
hybridization signal intensities and compared the difference in
fluorescence intensity between spots encoding homologous versus
nonhomologous targets. (This ratio of fluorescence values served as a
way of normalizing data across many different arrays, with the
cross-hybridization background always assigned an arbitrary value of 50 fluorescence units.) Initial experiments detected approximately
threefold variations in signal intensity, which seemed to correlate
with changes in spot size (data not shown). Furthermore, arrays
prepared early in the production cycle produced the most-intense
signals, while later batches of slides, encoding smaller spots,
produced weaker fluorescence signals. This effect was caused by the
arraying pins blunting with use, causing the spots to decrease in
radius from ~75 to ~45 µm. This should reduce the quantity of
bound DNA approximately threefold (
2), which
agreed well with the observed variation in fluorescence intensities.
Figure 2 shows a representative selection
of results subsequently obtained from 10 separate hybridization
experiments using arrays bearing primarily 45-µm (radius) spots. The
signal intensity still varied in these experiments from target to
target, ranging from 180 to 1,090 arbitrary fluorescence units, but the fluorescence intensities measured at sites encoding homologous target
sequences were always significantly greater (at least threefold) than
the signals detected elsewhere on the array at nonhomologous targets.
Several additional factors probably contribute to the residual
variation, including variations in the concentrations and specific
activities of fluorescent probes. However, a significant confounding
factor appeared to be the size of the target DNA.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 2.
Quantitation of hybridization signals. A glass
background value was automatically subtracted from all measured
fluorescence intensities, and the mean intensity and standard deviation
(n = 4) were then calculated for each spot. To permit
comparison between different arrays and probes, the average nonspecific
cross-hybridization signal detemined at nonhomologous targets was
assigned an arbitrary value of 50 fluorescence units. In all cases, a
clear hybridization signal was readily differentiated from this
nonspecific background.
|
|
Effect of target length on signal intensity.
The primers used
in this study were designed to create some overlap between the two or
three target cDNAs derived from any given influenza virus gene. This
made it possible to estimate what minimal target sequence length might
be required to produce a hybridization signal. For example, targets
A/HA2-1 and A/HA2-2 have 202 bp of common sequence and, by hybridizing
a probe derived from A/HA2-1 to these arrays, one can measure the
relative efficiency of probe binding to target A/HA2-1 (513 homologous
base pairs) or to A/HA2-2 (202 homologous base pairs) (Fig. 1, panels 8 and 10). The results derived from this analysis are shown in Fig. 3. Generally it was noted that overlaps
of less than ~100 bp produced poor or no hybridization signals,
suggesting that this represents the minimal length of target required
under these conditions. In contrast, overlapping sequences in excess of
~100 bp produced readily detectable fluorescence signals and the
intensity appeared roughly dependent on the length of the overlapping
region common to target and probe.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 3.
Hybridization signals depend on the length of homology.
Hybridization signals were measured using a variety of probes and
targets, and the fluorescence intensity was plotted as a function of
the number of base pairs common to each probe and target. Positive
hybridization signals were significantly differentiated from a
nonspecific cross-hybridization background when the amount of base
overlap exceeded 100 to 150 bp.
|
|
To further test what effect longer targets have on signal intensity, we
took advantage of the fact that other primer combinations can be used
to produce a cDNA fragment spanning two or more target DNAs in a single
RT-PCR. For example, a reaction with primers 15 and 20 (Table 3)
generates a 1,607-bp probe fragment spanning targets A/HA3-1 (520 bp),
A/HA3-2 (444 bp), and A/HA3-3 (707 bp). This method of probe
preparation ensured that differences in the concentrations and specific
activities of probes weren't responsible for variations in
hybridization efficiency. As expected, this now uniformly labeled DNA
hybridized to all three homologous targets on a single array (Fig. 1,
panel 7), and again no significant cross-hybridization was detected.
Quantitation of the fluorescence signals showed the relative intensity
ratios to be 1.2 (A/HA3-1) to 1.0 (A/HA3-2) to 2.1 (A/HA3-3), which
follows the same trend as the relative size ratios (1.2 [A/HA3-1] to
1.0 [A/HA3-2] to 1.6 [A/HA3-3]). Therefore, as with traditional
blotting technologies, DNA arrays produce hybridization signals which
are roughly proportional to target size.
Hybridization using mixed probes and multiple
dyes.
A double-labeling experiment was also conducted to further
test the discriminatory capacity of these arrays. Control experiments showed that a mixture of Cy3-labeled A/HA2-1 and B/NA-1 probes hybridized to the expected A/HA2-1 and B/NA-1 targets in a single array
(Fig. 1, panel 10) producing fluorescent spots of comparable intensities. No cross-hybridization signals were detected beyond some
additional binding to the A/HA2-2 locus (the A/HA2-1 probe has 202-bp
homology with an A/HA2-2 target). We then used different fluorescent
dyes to prepare A/HA2-1 probes labeled with Cy3-dCTP and B/NA-1 probes
labeled with Cy5-dCTP. The probes were mixed together in equal amounts
and hybridized to the array, and the bound fluorescent probes were then
detected using 543 (Cy3) and 635 nm (Cy5) as the excitation
wavelengths. The two resulting images are shown in Fig. 1, panels 8 and
9. Cy3- and Cy5-labeled probes seemed to hybridize with comparable
efficiencies, producing fluorescence signals of comparable intensities.
Moreover, the Cy3-labeled A/HA2-1 probes hybridized only to homologous
A/HA2-1 and (overlapping) A/HA2-2 targets and the Cy-5-labeled B/NA-1 probe hybridized to the B/NA-1 target. These data show that one can
differentiate a mixture of probes prepared using separate dyes and thus
derive additional information regarding the probe composition.
Multiplex PCR.
The preceding experiments showed that influenza
virus cDNA arrays can be used to accurately identify different model
probes either singly or in mixtures. However, the eventual goal of
these experiments is to improve on multiplex methods capable of typing and subtyping unknown viruses. We thus screened our primers for primer
combinations that are compatible in multiplex RT-PCRs. In recognition
of the fact that some gene combinations are mutually exclusive (e.g., a
virus is either H1 or H2 but can't be both), primer combinations that
should produce a single diagnostically informative PCR product in a
reaction with any given type or subtype of influenza virus were chosen.
After testing large numbers of primer combinations against a battery of
cDNAs templates, we eventually identified three multiplex primer
combinations that collectively type and subtype influenza strains.
These primer sets are summarized in Table
5. Figure 4 shows how
these multiplex primer combinations can
selectively amplify a particular gene target in reactions with one of
the primer mixtures and a particular cloned cDNA target. For example,
primer mixture A (Table 5) amplified an ~510-bp A/HA1-1 product in a
PCR with a cloned A/HA1-1 template (Fig. 4, lane b) as well as
~490-bp A/HA2-3, ~700-bp A/HA3-3, and ~530-bp B/MP-1 products in
PCRs with A/HA2-3, A/HA3-3, and B/MP-1 templates, respectively (Fig. 4,
lanes e, h, and k).

View larger version (81K):
[in this window]
[in a new window]
|
FIG. 4.
Multiplex PCR amplification of influenza A and B virus
strains. The three multiplex primer sets described in Table 5 were
tested for the capacity to amplify a single, appropriately sized, DNA
product in reactions with the indicated cloned templates. For example,
primer mixture A (Table 5) produced a 510-bp product in a reaction with
an A/HA1-1 template (lane b), a 490-bp product in a reaction with an
A/HA2-3 template (lane e), primarily a 710-bp product in a reaction
with an A/HA3-3 template (lane h), and a 530-bp product in a reaction
with B/MP-1 template (lane k). PCR products were separated using a
1.2% agarose gel and stained with ethidium bromide.
|
|
Typing and subtyping influenza viruses by RT-PCR and array
hybridization.
In a now more realistic test of this method we
examined whether the multiplex primers described in Table 5 can
actually type and subtype different influenza viruses. Three viral RNA
strains were tested (A/Denver/1/57 [H1N1], A/Victoria/3/75 [H3N2],
and B/Hong Kong/5/72), with A/Denver/1/57 and B/Hong Kong/5/72 being different from those strains used to prepare arrayed targets (Table 1).
None of the sequences targeted in strains A/Denver/1/57 and B/Hong
Kong/5/72 were known to us when the work started, nor was the sequence
of the MP gene of A/Victoria/3/75. Multiplex RT-PCR succeeded in
producing all six of the six possible probes from mixtures containing
influenza A virus RNA (HA1-1, HA3-3, NA1-1, NA2-2, and two MP-1 gene
fragments) and two of the three possible probes from mixtures
containing influenza B virus RNA (HA-1 and NA-1). In all cases only a
single product was detected by agarose gel electrophoresis (data not
shown). These cDNA probes correctly hybridized to targets specific for
each particular type and subtype of virus (e.g., Fig. 1, panels 11 and
12), and the hybridization signals were again well above the background
detected at nonhomologous spots (Fig. 5).

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 5.
RT-PCR detection and differentiation of influenza virus
RNA templates. The multiplex primers indicated in Table 5 were tested
for the capacity to type and subtype the indicated influenza virus
strains. Probes were prepared in reaction mixtures containing crude
viral RNA, Cy3-dCTP, and an appropriate multiplex primer mixture and
hybridized overnight to microarrays. The signal intensity was
calculated as described in Materials and Methods (n = 4). Signals marked with an asterisk derive from perfectly matched
probe-and-target pairs (i.e., the probe is identical to the arrayed
target), and the remaining signals represent heterologous
probe-and-target combinations (i.e., the target DNA came from a strain
different from that tested in this experiment).
|
|
 |
DISCUSSION |
Although DNA arrays have been most widely utilized by the genomics
research community to study gene expression patterns and identify new
genes, many authorities have speculated that they might also prove
useful in DNA-based diagnostics. In this paper we have shown that
robotically spotted DNA chips, when used in conjunction with multiplex
PCR methods, can be used to facilitate typing and subtyping human
influenza viruses. Since the method exploits the specificity of both
PCR and DNA hybridization reactions, it offers a degree of accuracy
superior to those of many other methods commonly used to detect
PCR-amplified DNAs. Thus it should be attractive in situations, such as
medical diagnostics and forensics, where further identification of a
PCR-amplified DNA may be required. The method is obviously applicable
to any pathogen that can be cloned and arrayed and offers the advantage
that one can detect and differentiate DNAs contained in mixtures of
fluorescent PCR products (Fig. 1, panel 10). This suggests that DNA
arrays could streamline the detection of multiple agents through
parallel analysis of pools of PCR-amplified DNAs.
Several features of gene chips, PCR, and fluorescent probes facilitated
the work outlined in this paper. First, PCR is well known for its
extraordinary sensitivity and can be used to generate large quantities
of probe DNA. Second, nucleotide-linked Cy3 and Cy5 dyes are readily
incorporated into PCR products without greatly interfering with the
efficiency of amplification or the yield of the probe. Third, these
dyes are intensely fluorescent and hybridization is easily detected at
levels well above background using modern confocally based array
readers. Finally, the hybridization and wash protocols differ little
from the more-traditional methods used with other nucleic acid binding
membranes, and thus experience with traditional methods is directly
applicable to the glass arrays used in these studies.
The preparation of DNA arrays used now fairly standard technology. We
fixed DNA to the slide surface using a 5'-amine-tagged oligonucleotide
and carbodiimide cross-linker. This method seems to provide a more
stable array and works well if, as was done here, cloned inserts can be
reamplified using a single pair of primers directed against flanking
vector sequences. However, the high cost of amine-linked primers
renders the method impractical if many different modified primers are
desired. In such situations we have employed noncovalent binding
methods with comparable success (J. Li and D. H. Evans,
unpublished data). To prepare DNA arrays capable of typing and
subtyping human influenza A and B virus strains, we designed 52 primers
theoretically capable of amplifying 26 different portions of the
influenza A and B virus HA, NA, and MP genes (Table 3). These primers
amplified all but two of the intended targets in standard RT-PCRs. One
of the two failures (B/MP-2) required primers that bind to sequences
poorly represented in the databases and thus may have been badly
designed; the failure of the other primer set (A/HA1-2) is
inexplicable. The 24 successfully amplified viral cDNAs nevertheless
provided a sufficiently redundant probe set for our purposes and were
cloned, sequenced, and arrayed.
These arrayed DNAs, each about 500 bp long, were readily hybridized to
probes prepared using the same cDNA templates (Fig. 1 and 2), with
signal-to-background ratios ranging from 6 to 30 (Fig. 2). No obvious
hybridization was detected at nonhomologous targets, and no
cross-hybridization was detected among the different subtypes of the
viruses. There was some expected cross-hybridization seen when probes
encoded sequences shared by two or more target sequences. Further
analysis of this phenomenon showed that >100 bp of homology was
required to produce any detectable binding (Fig. 3). This effect was
almost certainly due to the stringent annealing conditions we used to
ensure maximal specificity, with the hybridization temperature set
~15°C higher than is recommended by the manufacturer of the
hybridization buffer (Roche) for use in Southern blotting applications.
This feature is useful, because it ensures that primer-derived
sequences common to both PCR products and chip-bound targets will not
cross-hybridize if illegitimate sequences have accidentally
misamplified. We also noted that sensitivity was improved by increasing
the size of the target spot and by increasing the length of the
fluorescent probe (Fig. 1, panel 7). This last experiment also
illustrates an important advantage of arraying partially redundant gene
fragments rather than very large single cDNAs. The fact that a 1.6-kbp
probe hybridized to three separate HA3 gene fragments showed that the
cDNA encoded sequences spanning the entire gene. This provided an
additional check on the identity of the probe.
It was not obvious how sequence mismatches affected hybridization
efficiency. Using perfectly matched probes (i.e., probes derived from
the same cDNA clones as target DNAs) we noted signal-to-noise ratios
varying from 6 to 30 over a variety of gene fragments (Fig. 2). A
similar range of signal-to-noise ratios (5 to 24) was noted when
heterologous probes were prepared from viral isolates belonging only to
the same viral type and subtype as the target virus cDNAs (Fig. 5).
Analyzing the cause of this variation is difficult because it is hard
to measure the specific activities of fluorescent probes and because
there also appear to be target-specific variations in hybridization
efficiency even with identical probe-target pairs (Fig. 2). However, it
is encouraging to note that both targets A/HA1-1 and A/NA-1 (derived
from A/New Jersey/8/76) hybridized to probes derived from virus strain
A/Denver/1/57 with signal-to-background ratios of 5.5 and 5.8, respectively. Upon the conclusion of these experiments we directly
sequenced portions of these A/Denver/1/57-derived probes and
found that the sequenced portions had ~86% sequence identity with
the target DNAs (GenBank accession no. AF305216 and AF305218).
Similarly, B/HA-1 and B/NA-1 probes (derived from strain B/Hong
Kong/5/72) hybridized to targets derived from strain B/Maryland/1/59
with signal-to-background ratios of 19 and 24, respectively. In this
case sequencing detected ~96% sequence identity between probe and
target (GenBank accession no. AF305219 and AF305220), suggesting that
mismatches may reduce the amount of probe bound under these stringent
hybridization conditions. Nevertheless, it seems clear that, if PCR
primers of sufficiently broad utility can be designed, the great
variation in influenza virus gene sequences (Table 2) will not
seriously interfere with the application of this technology. We are
currently expanding the content of these arrays to permit detection of
a much greater selection of viral and other pathogens.
 |
ACKNOWLEDGMENTS |
We thank A. Hollis and B. Cooney for DNA sequencing.
This work was supported by an OMAFRA special research grant, the
Ontario Innovation Trust, and the Canadian Foundation for Innovation.
Research in D.E.'s laboratory was supported by NSERC and CIHR grants.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Molecular Biology and Genetics, University of Guelph, Guelph, Ontario N1G 2W1, Canada. Phone: (519) 824-4120, ext. 2575. Fax: (519) 837-2075. E-mail: dhevans{at}uoguelph.ca.
 |
REFERENCES |
| 1.
|
Anthony, R. M.,
T. J. Brown, and G. L. French.
2000.
Rapid diagnosis of bacteremia by universal amplification of 23S ribosomal DNA followed by hybridization to an oligonucleotide array.
J. Clin. Microbiol.
38:781-788[Abstract/Free Full Text].
|
| 2.
|
Atmar, R. L.,
B. D. Baxter,
E. A. Dominguez, and L. H. Taber.
1996.
Comparison of reverse transcription-PCR with tissue culture and other rapid diagnostic assays for detection of type A influenza virus.
J. Clin. Microbiol.
34:2604-2606[Abstract].
|
| 3.
|
Bowtell, D. D.
1999.
Options available from start to finish for obtaining expression data by microarray.
Nat. Genet.
21:25-32[CrossRef][Medline].
|
| 4.
|
Bressoud, A.,
J. Whitcomb,
C. Pourzand,
O. Haller, and P. Cerutti.
1990.
Rapid detection of influenza virus H1 by the polymerase chain reaction.
Biochem. Biophys. Res. Commun.
167:425-430[CrossRef][Medline].
|
| 5.
|
Brown, E. G.
2000.
Influenza virus genetics.
Biomed. Pharmacother.
54:196-209[CrossRef][Medline].
|
| 6.
|
Debouck, C., and P. N. Goodfellow.
1999.
DNA microarrays in drug discovery and development.
Nat. Genet.
21:48-50[CrossRef][Medline].
|
| 7.
|
Duggan, D. J.,
M. Bittner,
Y. Chen,
P. Meltzer, and J. M. Trent.
1999.
Expression profiling using cDNA microarrays.
Nat. Genet.
21:10-14[CrossRef][Medline].
|
| 8.
|
Favis, R.,
J. P. Day,
N. P. Gerry,
C. Phelan,
S. Narod, and F. Barany.
2000.
Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2.
Nat. Biotechnol.
18:561-564[CrossRef][Medline].
|
| 9.
|
Gerry, N. P.,
N. E. Witowski,
J. Day,
R. P. Hammer,
G. Barany, and F. Barany.
1999.
Universal DNA microarray method for multiplex detection of low abundance point mutations.
J. Mol. Biol.
292:251-262[CrossRef][Medline].
|
| 10.
|
Hacia, J. G.
1999.
Resequencing and mutational analysis using oligonucleotide microarrays.
Nat. Genet.
21:42-47[CrossRef][Medline].
|
| 11.
|
Hacia, J. G.,
J. B. Fan,
O. Ryder,
L. Jin,
K. Edgemon,
G. Ghandour,
R. A. Mayer,
B. Sun,
L. Hsie,
C. M. Robbins,
L. C. Brody,
D. Wang,
E. S. Lander,
R. Lipshutz,
S. P. Fodor, and F. S. Collins.
1999.
Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays.
Nat. Genet.
22:164-167[CrossRef][Medline].
|
| 12.
|
Hughes, T. R.,
C. J. Roberts,
H. Dai,
A. R. Jones,
M. R. Meyer,
D. Slade,
J. Burchard,
S. Dow,
T. R. Ward,
M. J. Kidd,
S. H. Friend, and M. J. Marton.
2000.
Widespread aneuploidy revealed by DNA microarray expression profiling.
Nat. Genet.
25:333-337[CrossRef][Medline].
|
| 13.
|
Kozal, M. J.,
N. Shah,
N. Shen,
R. Yang,
R. Fucini,
T. C. Merigan,
D. D. Richman,
D. Morris,
E. Hubbell,
M. Chee, and T. R. Gingeras.
1996.
Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays.
Nat. Med.
2:753-759[CrossRef][Medline].
|
| 14.
|
Magnard, C.,
M. Valette,
M. Aymard, and B. Lina.
1999.
Comparison of two nested PCR, cell culture, and antigen detection for the diagnosis of upper respiratory tract infections due to influenza viruses.
J. Med. Virol.
59:215-220[CrossRef][Medline].
|
| 15.
|
Pease, A. C.,
D. Solas,
E. J. Sullivan,
M. T. Cronin,
C. P. Holmes, and S. P. Fodor.
1994.
Light-generated oligonucleotide arrays for rapid DNA sequence analysis.
Proc. Natl. Acad. Sci. USA
91:5022-5026[Abstract/Free Full Text].
|
| 16.
|
Schena, M.,
D. Shalon,
R. W. Davis, and P. O. Brown.
1995.
Quantitative monitoring of gene expression patterns with a complementary DNA microarray.
Science
270:467-470[Abstract/Free Full Text].
|
| 17.
|
Schena, M.,
D. Shalon,
R. Heller,
A. Chai,
P. O. Brown, and R. W. Davis.
1996.
Parallel human genome analysis: microarray-based expression monitoring of 1000 genes.
Proc. Natl. Acad. Sci. USA
93:10614-10619[Abstract/Free Full Text].
|
| 18.
|
Schorr, E.,
D. Wentworth, and V. S. Hinshaw.
1994.
Use of polymerase chain reaction to detect swine influenza virus in nasal swab specimens.
Am. J. Vet. Res.
55:952-956[Medline].
|
| 19.
|
Schweiger, B.,
I. Zadow,
R. Heckler,
H. Timm, and G. Pauli.
2000.
Application of a fluorogenic PCR assay for typing and subtyping of influenza viruses in respiratory samples.
J. Clin. Microbiol.
38:1552-1558[Abstract/Free Full Text].
|
| 20.
|
Shalon, D.,
S. J. Smith, and P. O. Brown.
1996.
A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization.
Genome Res.
6:639-645[Abstract/Free Full Text].
|
| 21.
|
Sniegowski, P.
1999.
The genomics of adaptation in yeast.
Curr. Biol.
9:R897-R898[CrossRef][Medline].
|
| 22.
|
Stockton, J.,
J. S. Ellis,
M. Saville,
J. P. Clewley, and M. C. Zambon.
1998.
Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses.
J. Clin. Microbiol.
36:2990-2995[Abstract/Free Full Text].
|
| 23.
|
Taubenberger, J. K.,
A. H. Reid,
A. E. Krafft,
K. E. Bijwaard, and T. G. Fanning.
1997.
Initial genetic characterization of the 1918 "Spanish" influenza virus.
Science
275:1793-1796[Abstract/Free Full Text].
|
| 24.
|
Willer, D. O.,
G. McFadden, and D. H. Evans.
1999.
The complete genome sequence of shope (rabbit) fibroma virus.
Virology
264:319-343[CrossRef][Medline].
|
| 25.
|
Wilson, J. W.,
P. Bean,
T. Robins,
F. Graziano, and D. H. Persing.
2000.
Comparative evaluation of three human immunodeficiency virus genotyping systems: the HIV-GenotypR method, the HIV PRT GeneChip assay, and the HIV-1 RT line probe assay.
J. Clin. Microbiol.
38:3022-3028[Abstract/Free Full Text].
|
| 26.
|
Wright, K. E.,
G. A. Wilson,
D. Novosad,
C. Dimock,
D. Tan, and J. M. Weber.
1995.
Typing and subtyping of influenza viruses in clinical samples by PCR.
J. Clin. Microbiol.
33:1180-1184[Abstract].
|
| 27.
|
Zambon, M. C.
1999.
Epidemiology and pathogenesis of influenza.
J. Antimicrob. Chemother.
44(Suppl. B):3-9[Abstract].
|
| 28.
|
Zhang, W., and D. H. Evans.
1993.
PCR detection and differentiation of influenza virus A, B, and C strains, p. 374-382.
In
D. H. Persing, T. Smith, F. Tenover, and T. White (ed.), Diagnostic molecular microbiology. American Society for Microbiology, Washington, D.C.
|
| 29.
|
Zhang, W. D., and D. H. Evans.
1991.
Detection and identification of human influenza viruses by the polymerase chain reaction.
J. Virol. Methods.
33:165-189[CrossRef][Medline].
|
Journal of Clinical Microbiology, February 2001, p. 696-704, Vol. 39, No. 2
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.2.696-704.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Tsukamoto, K., Ashizawa, H., Nakanishi, K., Kaji, N., Suzuki, K., Okamatsu, M., Yamaguchi, S., Mase, M.
(2008). Subtyping of Avian Influenza Viruses H1 to H15 on the Basis of Hemagglutinin Genes by PCR Assay and Molecular Determination of Pathogenic Potential. J. Clin. Microbiol.
46: 3048-3055
[Abstract]
[Full Text]
-
Kerby, M. B., Freeman, S., Prachanronarong, K., Artenstein, A. W., Opal, S. M., Tripathi, A.
(2008). Direct Sequence Detection of Structured H5 Influenza Viral RNA. J. Mol. Diagn.
10: 225-235
[Abstract]
[Full Text]
-
Honma, S., Chizhikov, V., Santos, N., Tatsumi, M., do Carmo S. T. Timenetsky, M., Linhares, A. C., Mascarenhas, J. D. P., Ushijima, H., Armah, G. E., Gentsch, J. R., Hoshino, Y.
(2007). Development and Validation of DNA Microarray for Genotyping Group A Rotavirus VP4 (P[4], P[6], P[8], P[9], and P[14]) and VP7 (G1 to G6, G8 to G10, and G12) Genes. J. Clin. Microbiol.
45: 2641-2648
[Abstract]
[Full Text]
-
He, Q., Velumani, S., Du, Q., Lim, C. W., Ng, F. K., Donis, R., Kwang, J.
(2007). Detection of H5 Avian Influenza Viruses by Antigen-Capture Enzyme-Linked Immunosorbent Assay Using H5-Specific Monoclonal Antibody. CVI
14: 617-623
[Abstract]
[Full Text]
-
Mehlmann, M., Bonner, A. B., Williams, J. V., Dankbar, D. M., Moore, C. L., Kuchta, R. D., Podsiad, A. B., Tamerius, J. D., Dawson, E. D., Rowlen, K. L.
(2007). Comparison of the MChip to Viral Culture, Reverse Transcription-PCR, and the QuickVue Influenza A+B Test for Rapid Diagnosis of Influenza. J. Clin. Microbiol.
45: 1234-1237
[Abstract]
[Full Text]
-
Mehlmann, M., Dawson, E. D., Townsend, M. B., Smagala, J. A., Moore, C. L., Smith, C. B., Cox, N. J., Kuchta, R. D., Rowlen, K. L.
(2006). Robust Sequence Selection Method Used To Develop the FluChip Diagnostic Microarray for Influenza Virus.. J. Clin. Microbiol.
44: 2857-2862
[Abstract]
[Full Text]
-
Townsend, M. B., Dawson, E. D., Mehlmann, M., Smagala, J. A., Dankbar, D. M., Moore, C. L., Smith, C. B., Cox, N. J., Kuchta, R. D., Rowlen, K. L.
(2006). Experimental Evaluation of the FluChip Diagnostic Microarray for Influenza Virus Surveillance.. J. Clin. Microbiol.
44: 2863-2871
[Abstract]
[Full Text]
-
Chen, T.-C., Chen, G.-W., Hsiung, C. A., Yang, J.-Y., Shih, S.-R., Lai, Y.-K., Juang, J.-L.
(2006). Combining Multiplex Reverse Transcription-PCR and a Diagnostic Microarray To Detect and Differentiate Enterovirus 71 and Coxsackievirus A16.. J. Clin. Microbiol.
44: 2212-2219
[Abstract]
[Full Text]
-
Lodes, M. J., Suciu, D., Elliott, M., Stover, A. G., Ross, M., Caraballo, M., Dix, K., Crye, J., Webby, R. J., Lyon, W. J., Danley, D. L., McShea, A.
(2006). Use of Semiconductor-Based Oligonucleotide Microarrays for Influenza A Virus Subtype Identification and Sequencing. J. Clin. Microbiol.
44: 1209-1218
[Abstract]
[Full Text]
-
Garrido, P., Blanco, M., Moreno-Paz, M., Briones, C., Dahbi, G., Blanco, J., Blanco, J., Parro, V.
(2006). STEC-EPEC Oligonucleotide Microarray: A New Tool for Typing Genetic Variants of the LEE Pathogenicity Island of Human and Animal Shiga Toxin-Producing Escherichia coli (STEC) and Enteropathogenic E. coli (EPEC) Strains. Clin. Chem.
52: 192-201
[Abstract]
[Full Text]
-
Leinberger, D. M., Schumacher, U., Autenrieth, I. B., Bachmann, T. T.
(2005). Development of a DNA Microarray for Detection and Identification of Fungal Pathogens Involved in Invasive Mycoses. J. Clin. Microbiol.
43: 4943-4953
[Abstract]
[Full Text]
-
Hindiyeh, M., Levy, V., Azar, R., Varsano, N., Regev, L., Shalev, Y., Grossman, Z., Mendelson, E.
(2005). Evaluation of a Multiplex Real-Time Reverse Transcriptase PCR Assay for Detection and Differentiation of Influenza Viruses A and B during the 2001-2002 Influenza Season in Israel. J. Clin. Microbiol.
43: 589-595
[Abstract]
[Full Text]
-
Ivshina, A. V., Vodeiko, G. M., Kuznetsov, V. A., Volokhov, D., Taffs, R., Chizhikov, V. I., Levandowski, R. A., Chumakov, K. M.
(2004). Mapping of Genomic Segments of Influenza B Virus Strains by an Oligonucleotide Microarray Method. J. Clin. Microbiol.
42: 5793-5801
[Abstract]
[Full Text]
-
Boriskin, Y. S., Rice, P. S., Stabler, R. A., Hinds, J., Al-Ghusein, H., Vass, K., Butcher, P. D.
(2004). DNA Microarrays for Virus Detection in Cases of Central Nervous System Infection. J. Clin. Microbiol.
42: 5811-5818
[Abstract]
[Full Text]
-
Kessler, N., Ferraris, O., Palmer, K., Marsh, W., Steel, A.
(2004). Use of the DNA Flow-Thru Chip, a Three-Dimensional Biochip, for Typing and Subtyping of Influenza Viruses. J. Clin. Microbiol.
42: 2173-2185
[Abstract]
[Full Text]
-
Boivin, G., Cote, S., Dery, P., De Serres, G., Bergeron, M. G.
(2004). Multiplex Real-Time PCR Assay for Detection of Influenza and Human Respiratory Syncytial Viruses. J. Clin. Microbiol.
42: 45-51
[Abstract]
[Full Text]
-
Sengupta, S., Onodera, K., Lai, A., Melcher, U.
(2003). Molecular Detection and Identification of Influenza Viruses by Oligonucleotide Microarray Hybridization. J. Clin. Microbiol.
41: 4542-4550
[Abstract]
[Full Text]
-
Shi, R. Z., Morrissey, J. M., Rowley, J. D.
(2003). Screening and Quantification of Multiple Chromosome Translocations in Human Leukemia. Clin. Chem.
49: 1066-1073
[Abstract]
[Full Text]
-
Bekal, S., Brousseau, R., Masson, L., Prefontaine, G., Fairbrother, J., Harel, J.
(2003). Rapid Identification of Escherichia coli Pathotypes by Virulence Gene Detection with DNA Microarrays. J. Clin. Microbiol.
41: 2113-2125
[Abstract]
[Full Text]